Research has demonstrated that excess glutamate accumulated in the human body is implicated in brain damage, kidney and liver disorders, obesity, reproductive disorders, neurodegenerative disease, and additional disorders such as headaches, asthma, diabetes, muscle pain, atrial fibrillation, ischemia, trauma, seizures, stroke, Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Huntington’s disease, Parkinson’s disease, depression, multiple sclerosis, schizophrenia, obsessive-compulsive disorder (OCD), epilepsy, addiction, attention-deficit/hyperactivity disorder (ADHD), frontotemporal dementia and autism. A November 15, 2020 search of the National Library of Medicine using PubMed.gov returned 3872 citations for “glutamate-induced.
It has also been demonstrated that glutamate from exogenous (external) sources, often from ingestion of monosodium glutamate (MSG), produces brain lesions, reproductive disorders, gross obesity, and behavior disorders. A review of the literature has also demonstrated that studies concluding MSG is harmless, or finding no evidence that MSG is harmful, are seriously flawed, with double-blind studies using placebos containing excitotoxic amino acids that cause reactions identical to those caused by MSG.
So why aren’t researchers exploring the relationship between ingestion of glutamate-containing ingredients such as MSG and disease and disability?